期刊文献+

地塞米松注射液对大鼠细胞色素P4502D6的影响

Effect of dexamethasone sodium phosphate injection on the cytochrome P4502D6 in rat
下载PDF
导出
摘要 目的观察地塞米松(激素类药物)注射液对大鼠细胞色素P4502D6(CYP2D6)亚型的影响。方法 SD大鼠,雌雄各半,随机分成2组,地塞米松组按50mg·kg-1尾静脉给药,对照组按10mL.kg-1尾静脉给生理盐水,给药7d后,每组给予氢溴酸右美沙芬注射液5mg·kg-1;按时间从大鼠眼静脉取血10次,血样处理后,用HPLC法同时测定大鼠血浆CYP2D6R探针药物右美沙芬及其代谢产物去甲右美沙芬浓度,用DAS2.0软件进行分析,求出其主要药代动力学参数。结果地塞米松组与对照组比较,对右美沙芬t1/2无显著性差异;而AUC0-t右美沙芬为(63.43±7.71)mg·mL-1.min,与对照组(41.07±4.63)mg.L-1.min比较有显著性差异(P<0.05)。结论地塞米松注射液对右美沙芬有一定诱导作用,可以促进合用药物的消除,从而加速其代谢。 Objective To study effect of CYP2D6 subtypes with dexamethasone sodium phosphate injection in rats.Methods A total of 12 SD rats were randomly divided into two groups:dexamethasone group(50 mg·kg-1)and normal saline group(10 mL·kg-1),which were intravenous medication.After seven days,two groups were injected dextromethorphan(5 mg·kg-1),then RP-HPLC method was used to determine the concentrations of dextromethorphan and dextrorphan in rats plasma at different time.Pharmacokinetic model and parameters were analyzed by Drug and Statistics(DAS 2.0).Results There was significant difference in pharmacokinetic parameter AUC of dexamethasone sodium phosphate injection(63.43±7.71)mg·L-1·min and control group(41.07±4.63)mg·L-1·min and there was no significant difference in pharmacokinetic parameter t1/2 between the two groups.Conclusion Dexamethasone injection have induction to dextromethorphan,so it could promote elimination with combination drugs,which was enhance the metabolism effects.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2010年第12期916-919,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家科技支撑计划基金资助项目(2006BAIB03206) 广东省科技计划基金资助项目(2008B030301035) 广东省中医药局基金资助项目(2009248)
关键词 地塞米松注射液 右美沙芬 去甲右美沙芬 细胞色素P4502D6酶 dexamethasone injection dextromethorphan dextrorphan cytochrome P4502D6
  • 相关文献

参考文献3

  • 1Smith DA,Bel SM,Hyland R,et al.Human cytochrome P450s:seleetivity and measurement in vivo[J].Xenobiotiea,1998;28:1095-1128.
  • 2桂淑玉,王勇生,李永怀,周青,胡向阳,吴强,汪渊.地塞米松对哮喘动物模型支气管平滑肌MLCK表达的影响[J].中国药理学通报,2005,21(7):872-875. 被引量:8
  • 3国家食品药品监督管理局药品审评中心.含绿原酸中药注射剂的安全性问题研究总结报[EB/OR].http://www.cde.org.cn/dzkw.do?method=largePage&id=307,2006-10-24.

二级参考文献10

  • 1Herring BP, Gallagher PJ, Stull JT. Substrate specificity of myosin light chain kinases[J]. J Biol Chem,1992,267(36):25945-50.
  • 2Van Eyk JE, Arrell DK, Foster DB et al. Different molecular mechanisms for Rho family GTPase-dependent, Ca2+-independent contraction of smooth mucle[J]. J Biol Chem,1998,273(36):23433-9.
  • 3Jiang H, Rao K, Liu X et al.Early changes in airway smooth muscle hyperresponsiveness[J].Can J Physiol Pharmacol,1994,72(11): 1440-7.
  • 4Vanacker NJ, Palmans E, Kips JC et al. Fluticasone inhibitis but dose not reverse allergen-induced structural airway changes[J].Am J Respir Crit Care Med,2001,163:674-9.
  • 5Ma X, Cheng Z, Kong H et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects[J].Am J Physiol Lung Cell Mol Physiol,2002,283(6):1181-9.
  • 6Stephens NL, Li W, Jiang H et al. The biophysics of asthmatic airway smooth muscle[J].Respir Physiol Neurobiol,2003,137(2-3):125-40.
  • 7Adachi T,Stafford S,Kayaba H et al.Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase-dependent manner[J].J Allergy Clin Immunol,2003,111(1):113-6.
  • 8Greenberg AK, Hu J, Basu S et al. Glucocorticoids inhibit lung cancer cell growth through the extracellular signal-related kinase pathyway and cell cycle regulators[J].Am J Respir Cell Mol Biol, 2002,27(3):320-8.
  • 9Derom E, Van Schoor J, Verhaeghe W et al. Systemic effects of inhaled fluticasone propionate and budesonide in adult patient with asthma[J].Am J Respir Crit Care Med,1999,160(1):157-61.
  • 10中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3565

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部